Related Experiment Videos
Epidemiology of cardiovascular disease in systemic lupus erythematosus
1SUNY Health Science Center at Brooklyn, NY 11203, USA.
Lupus
|May 11, 2000
Insights
Cardiovascular disease significantly impacts long-term health and survival in patients with Systemic Lupus Erythematosus (SLE). Accelerated atherosclerosis is a key concern, as evidenced by clinical events in global lupus patient groups.
Area of Science:
- Rheumatology
- Cardiology
- Epidemiology
Background:
- Growing awareness of cardiovascular disease (CVD) risks in Systemic Lupus Erythematosus (SLE) patients.
- Clinical events linked to accelerated atherosclerosis are increasingly documented in global SLE cohorts.
- Understanding CVD's role in SLE morbidity and mortality is crucial.
Purpose of the Study:
- To review the historical context of cardiovascular disease in SLE.
- To examine the epidemiology of cardiovascular disease within SLE patient populations.
- To synthesize current knowledge on CVD in SLE.
Main Methods:
- Literature review of historical data.
- Analysis of epidemiological studies on SLE and CVD.
- Synthesis of documented clinical events in SLE cohorts.
Main Results:
- Evidence of accelerated atherosclerosis in SLE patients globally.
- Clinical events related to CVD are prevalent in SLE.
- Historical trends and current epidemiological data highlight CVD as a major concern.
Conclusions:
- Cardiovascular disease is a significant contributor to late morbidity and mortality in SLE.
- Accelerated atherosclerosis is a primary mechanism for CVD in SLE.
- Further research and clinical attention are warranted for CVD prevention in SLE patients.
Abstract:
Awareness of the impact of cardiovascular disease on the late morbidity and mortality in patients with Systemic Lupus Erythematosus (SLE) is increasing. Clinical events secondary to accelerated atherosclerosis have been documented in lupus cohorts across the globe. We review the history and epidemiology of cardiovascular disease in patients with SLE.